The intracranial aneurysm market size was valued at USD 1.63 billion in 2024 and is expected to reach USD 3.24 billion by 2032, growing at a CAGR of 9.00% over 2025-2032.
To Get more information on Intracranial Aneurysm Market - Request Free Sample Report
The intracranial aneurysm market is further expected to grow due to the rising detection rate of unruptured aneurysms, rising preference for minimally invasive procedures, and technological advancements taking place in the market. Studies show that up to 3–5% of the global population have unruptured intracranial aneurysms, with prevalence increasing in women and the elderly. Endovascular coiling is now responsible for more than 60–65% of treatments globally, and its use is increasing in Asia-Pacific and Latin America, where there is greater access to hospitals and education for specialist training. The use of flow diverters is growing at a rate of more than 12% annually due to their efficacy in the treatment of wide-neck, large aneurysms not conducive to coil indwelling.
Investment in the development of R&D is increasing for major payers, at between 10–12% of annual revenue, and is now being directed into innovation in microcatheters, intrasaccular implants, and embolization systems. Over 30 neurovascular devices have gained regulatory approval (FDA, CE Mark) as of 2022, suggesting a robust innovation pipeline. The artificial intelligence (AI) driven aneurysm detection software and robot-assisted navigation system have been deployed in neurosurgical institutions, which are expected to improve the accuracy of diagnosis and procedure accuracy for additional treatment. In addition, the growing availability of DSA and 3D rotational angiography at regional and national centers is enhancing case recognition and preoperative assessment.
Policy-wise, the U.S., Germany, and Japan reimbursement models are growing more friendly to newer technologies such as flow diverters, driving clinical adoption. At the same time, the adoption of UHC models by a number of emerging economies is contributing to narrowing the gap in treatment access. Combined, these trends posit ongoing intracranial aneurysm market growth due to increasing demand, increasing supply chain, evolving clinical practice angle, and constant signal innovations.
Table: Clinical Pipeline Snapshot – Late-Stage Devices (as of 2025)
|
Sponsor |
Device/Approach |
Trial Phase |
Target Indication |
Expected Launch |
|
Cerus Endovascular |
Contour 2nd Gen |
Phase III |
Wide-neck Aneurysms |
Q4 2025 |
|
Rapid Medical |
TIGERtriever Flow |
Phase II/III |
Ruptured Aneurysms |
2026 |
|
Sequent Medical |
MicroCoil (Bioactive) |
Phase III |
Distal Aneurysms |
2025 |
|
InNeuroCo |
NeuroGuard System |
Phase II |
Aneurysm + Clot Protection |
2026 |
Drivers:
Rising Disease Burden, Technological Advancement, and Favorable Regulatory and Investment Dynamics Fuel Market Growth
The intracranial aneurysm market growth is driven by the rising incidence of neurovascular diseases and the rising popularity of minimally invasive methods. About 30,000 people have aneurysm rupture every year in the U.S., making the need for advancements in early diagnosis and treatment essential. Advanced imaging capabilities like 4D CTA and MRI angiogram are facilitating early detection, while next-generation flow diverters and embolic coils are increasing the options for the treatment of earlier deemed inoperable aneurysms. Rising R&D activity is also stoking market growth, with Balt, Sequent Medical, and NeuroVasc, for instance, investing heavily in pipeline innovation, with R&D spend growing at around 10–15% per year in leading players.
Regulatory agency assessments are being prioritized to streamline access, including the FDA’s Breakthrough Device Designation for the eCLIPs Bifurcation Flow Diverter, granted in 2023, to expedite entry to market. The proliferation of both public-private partnerships and neurovascular-focused investment, more than USD 250 million over the past 24 months globally, is also driving device availability and innovation. Moreover, rising physician enlightenment and the development of neurovascular training programs around the world mean that there's more availability of treatments over the long run. Taken together, these parts point to the continued intracranial aneurysm market expansion and are the result of innovation, clinical need, and regulatory aid.
Restraints:
The Major Limitations in Market Expansion, Such as Procedural Risk, Access Gaps, Cost Burdens, and Lack of Skilled Specialists in Emerging Economies
Multiple barriers to the market may limit its adoption and access, even with strong innovation. One set of barriers centers around procedural cost and device price, and there are no unreasonable concerns about that with devices like flow diverters, which come to USD 15,000–25,000 dollars a device, and so those are completely unaffordable to most people in low- and middle-income countries. In addition, the technical expertise is in high demand, and there is a lack of neuro-interventionalists working globally, especially in non-metropolitan regions. In rural and underdeveloped areas, basic neuroimaging such as CTA and DSA is scarce, which leads to a late diagnosis, resulting in limited ineligible for advanced intervention. Moreover, safety issues regarding long-term follow-up (e.g., in-stent thrombosis, delayed rupture after the deployment) would explain the conservative clinical uptake in some areas.
Reimbursement issues continue as well; most national health systems are unwilling to pay for these newer, high-cost devices in the absence of robust cost-effectiveness data, impeding product acceptance. Moreover, in some markets, the level of regulation in place also contributes to time-to-market issues. These limitations shed light on the broader policy pathway, economic accessibility, and workforce development to achieve fair growth and reach the global intracranial aneurysm market trends.
By Product Type
By 2024, aneurysm therapeutic devices held a major share of the intracranial aneurysm market, with an overall market value of 64%. This superiority is due to the wide use of therapeutic equipment, such as detachable coils, embolization materials, flow diverters, and occlusion catheters, necessary for surgical and endovascular treatments. Given their safety, efficacy, and clinical adaptability, such devices are currently used in hospitals and specialty settings.
Among this category, flow diverters are growing the most rapidly and are expected to gain further ground given the success of treating the wide-neck and large Aneurysms with fewer procedural complications and lower retreatment rates. Material advancements, visibility, and accommodating complex anatomy have also started to speed up acceptance by neurointerventionalists. Even if the segment of population represented by patients who are ineligible for standard coiling is slowly emerging, due to increasing regulatory approvals and good long-term occlusion rates.
By Aneurysm Type
Saccular aneurysms dominated the product landscape in 2024, with more than 70% of the overall cases treated owing to high prevalence and established treatment guidelines. These aneurysms, which often form at bifurcations of cerebral arteries, can be more readily imaged and respond to traditional endovascular treatments, such as coiling and flow diversion, the report added. The rising trend of screening tests, including CT angiography and MR angiography, has contributed to the advancement in early diagnosis, thereby making it the largest segment.
Conversely, mycotic aneurysms are the segment experiencing the highest growth rate due to increasing complications of infection, particularly in immunocompromised and elderly patients. The second type of aneurysms is less common and represent an emergency clinical situation that demands aggressive treatment, with a high risk of aneurysm rupture. Awareness, microbiological diagnostics, and therapeutic strategies need to be enhanced including individualized (targeted) antibiotic strategies as more and more patients are treated (surgically/ endovascularly) for their management.
By Treatment Type
In 2024, endovascular coiling was the most common treatment, with endovascular coiling representing 61% of all treatments globally. It is popular because of less-invasiveness, shorter hospitalization, and high safety. It continued to be the standard of care for small to medium aneurysms, especially in poor open surgical candidate patients. The development of improved devices with bioactive and detachable coils has led to better clinical outcomes and low recurrence rates.
The most rapidly growing treatment category is flow diverters, which are more commonly used for the treatment of large, wide-necked aneurysms that are not suitable for coiling or clipping. They can change blood flow and occlude the aneurysms in long-term follow-up without entering to aneurysm sac, and that is why they are chosen for use. Late clinical experience and gaining registration of newer-generation devices foster physician confidence in and procedural preference for EVT, particularly in tertiary care and neuro-specialty centers.
By End-User
Hospitals accounted for the largest share of the intracranial aneurysm market trends in 2024 and are expected to account for 68% of all procedures performed. They have become the standard owing to modern neuroimaging equipment, hybrid operating rooms, trained neurointerventionists, and postoperative care support. Hospitals are also the place of the most high-risk and emergency cases of aneurysm, especially ruptures, which demand immediate help. The centralized availability of multidisciplinary assessment teams and emergency intervention services also enhances the role of the teams in aneurysm care.
Specialty clinics, on the other hand, recorded the highest CAGR, as the trend towards outpatient care and dedicated neurosurgery centers reinforced their demand. The surge in CPT chimeric days is driven by progress in compact imaging systems, manageable day-care surgery, and increasing insurance coverage of outpatient neurointerventional procedures. These clinics have reduced turnaround time, lower procedural costs, and personalized patient care, and they are desirable for elective, unruptured aneurysm patients in urban settings.
In 2024, North America held a major position in the intracranial aneurysm market share, primarily owing to its well-established healthcare infrastructure, high adoption of minimally invasive neurosurgical procedures, and favorable reimbursement policies.
The U.S. intracranial aneurysm market size was valued at USD 0.61 billion in 2024 and is expected to reach USD 1.18 billion by 2032, growing at a CAGR of 8.68% over 2025-2032. The leading position of the U.S. can be attributed to the high number of intracranial procedures, the existence of major neurovascular devices manufacturers, and large hospital networks. Endovascular coiling was the dominant treatment in U.S. aneurysm procedures in 2024, consisting of more than four-fifths of all cases. Canada was also seeing an upward trend, mainly due to enhanced access to neuroimaging and increases in government-sponsored aneurysm screening. The U.S. is the leading market contributor, with a large intracranial aneurysm market share accounting for the initial adoption of advanced technology, FDA-approved technology, and also aging population with the elevated occurrence of aneurysms. The increasing prevalence of lifestyle-related risk factors like high blood pressure and smoking can only stoke the market in this region.
Table: Regulatory Approvals of Key Intracranial Aneurysm Devices (2022–2025)
|
Company |
Device Name |
Regulatory Body |
Approval Type |
Date |
|
MicroVention |
WEB 17 System |
FDA |
PMA |
June 2024 |
|
Stryker |
Contour Neurovascular |
CE Mark |
Commercial Use |
May 2025 |
|
Balt |
Silk Vista Baby |
FDA |
510(k) |
Feb 2025 |
|
Phenox GmbH |
pEGASUS Stent |
CE Mark |
New Device |
Mar 2025 |
|
Terumo |
SOFIA Catheter (update) |
PMDA (Japan) |
Expansion |
Oct 2024 |
Europe is the second-largest growing region due to rising technological improvements, favorable reimbursement policies, and strong R&D investment in neurovascular treatment. Germany is a frontrunner in the intracranial aneurysm market owing to high procedural volume, government-initiated health insurance, and the presence of leading medical device companies. There is also a substantial contribution from France and the UK, where demand can now be attributed to an increase in elective endovascular procedures and exposure to neurointervention trainees. Germany is a significant player in the European market with highly developed neurovascular centers and access to DSA and hybrid ORs. There were more than 40,000 intracranial aneurysm procedures in Germany in 2024, and demand is high for flow diverters and embolization devices. Furthermore, the growing uptake of robotic-assisted devices and EU CE-mark clearances is driving market penetration in Western and Eastern Europe.
The Asia Pacific is the fastest-growing region of the intracranial aneurysm market analysis due to the increasing healthcare investments, growing medical infrastructure, and awareness regarding neurological disorders.
High procedural volume in Japan is attributed to a high prevalence of intracranial aneurysms and early adoption of advanced neurovascular devices. In 2024, more than 50,000 intracranial interventions are performed in Japan, with a preference for flow diverters and microcatheter-based coiling. China is in a period of rapid development, receiving large investments from the government and private sectors for neurosurgery centers and possessing a vast patient population. The market is being expanded by the Chinese government’s drive for the provision of universal access to healthcare and domestic manufacture of embolic devices. India is also developing as a hotspot for growth, thanks to improved availability of neuro-specialty hospitals and growing patient knowledge. The regulatory infrastructure in the region has been improving, and CRO firms and companies like MicroPort and Terumo have been conducting clinical trials, which is also encouraging this growth.
Get Customized Report as per Your Business Requirement - Enquiry Now
Leading intracranial aneurysm treatment companies in the market include Medtronic, Stryker, MicroPort Scientific Corporation, Johnson & Johnson Services, Inc., MicroVention Inc., B. Braun SE, Integra LifeSciences, RAUMEDIC AG, Terumo Corporation, Delta Surgical, Penumbra, Inc., Balt, Wallaby Medical, Shape Memory Medical Inc., Zylox-Tonbridge Medical Technology Co., Ltd., Spartan Micro, Inc., Mizuho Medical Co., Ltd., Lepu Medical Technology Co., Ltd., Phenox GmbH, and Peter LAZIC GmbH.
In May 2025, Stryker Corporation published a meta-analysis of nearly 500 patients showing high safety and efficacy of the Contour Neurovascular System, strengthening its clinical validation for wide-neck bifurcation aneurysms.
In February 2025, Balt USA received FDA 510(k) clearance for its Silk Vista Baby flow diverter, designed for small distal vessels, expanding treatment options for previously hard-to-reach aneurysms.
| Report Attributes | Details |
|---|---|
| Market Size in 2024 | USD 1.63 billion |
| Market Size by 2032 | USD 3.24 billion |
| CAGR | CAGR of 9.00% From 2025 to 2032 |
| Base Year | 2024 |
| Forecast Period | 2025-2032 |
| Historical Data | 2021-2023 |
| Report Scope & Coverage | Market Size, Segments Analysis, Competitive Landscape, Regional Analysis, DROC & SWOT Analysis, Forecast Outlook |
| Key Segments | • By Product Type (Aneurysm Therapeutic Devices [Clips, Coils, Intravascular Devices, Flow Diverters, Embolization Devices, Occlusion Catheters, Embolic Agents], Aspiration Devices [Aspiration Catheters, Clot Retrieval Devices], Access Devices [Micro Catheters, Guidewires]) • By Aneurysm Type (Saccular Aneurysm, Fusiform Aneurysm, Mycotic Aneurysm) • By Treatment Type (Surgical Clipping, Endovascular Coiling, Flow Diverters, Others [Bypass surgery, Stent-assisted coiling]) • By End-User (Hospitals, Specialty Clinics, Others [Ambulatory Surgical Centers, Academic Institutes]) |
| Regional Analysis/Coverage | North America (U.S., Canada), Europe (Germany, France, UK, Italy, Spain, Russia, Poland, Rest of Europe), Asia Pacific (China, India, Japan, South Korea, Australia, ASEAN Countries, Rest of Asia Pacific), Middle East & Africa (UAE, Saudi Arabia, Qatar, Egypt, South Africa, Rest of Middle East & Africa), Latin America (Brazil, Argentina, Mexico, Colombia, Rest of Latin America) |
| Company Profiles | Medtronic, Stryker, MicroPort Scientific Corporation, Johnson & Johnson Services, Inc., MicroVention Inc., B. Braun SE, Integra LifeSciences, RAUMEDIC AG, Terumo Corporation, Delta Surgical, Penumbra, Inc., Balt, Wallaby Medical, Shape Memory Medical Inc., Zylox-Tonbridge Medical Technology Co., Ltd., Spartan Micro, Inc., Mizuho Medical Co., Ltd., Lepu Medical Technology Co., Ltd., Phenox GmbH, and Peter LAZIC GmbH. |
Ans: The market is driven by the rising incidence of unruptured aneurysms due to increased neuroimaging, growing preference for minimally invasive endovascular procedures, and technological advancements like flow diverters and embolization devices.
Ans: Endovascular coiling is the most widely adopted treatment, followed by flow diverters and surgical clipping, with endovascular approaches gaining dominance due to reduced invasiveness and faster recovery.
Ans: Flow diverters are witnessing high adoption with a projected CAGR exceeding 10%, due to their effectiveness in treating complex and large aneurysms that are not suitable for coiling or clipping.
Ans: North America holds the largest market share due to high procedure volumes and advanced healthcare infrastructure, while Asia-Pacific is the fastest-growing region, driven by increasing healthcare access, awareness, and investments.
Ans: Key players include Medtronic, Stryker, Johnson & Johnson Services, Inc., Terumo Corporation, MicroPort Scientific Corporation, and Penumbra, Inc., all of whom are focusing on R&D, FDA approvals, and global expansion.
Table Of Contents
1. Introduction
1.1 Market Definition & Scope
1.2 Research Assumptions & Abbreviations
1.3 Research Methodology
2. Executive Summary
2.1 Market Snapshot
2.2 Market Absolute $ Opportunity Assessment & Y-o-Y Analysis, 2021–2032
2.3 Market Size & Forecast, By Segmentation, 2021–2032
2.3.1 Market Size By Product Type
2.3.2 Market Size By Aneurysm Type
2.3.3 Market Size By Treatment Type
2.3.4 Market Size By End-user
2.4 Market Share & BPS Analysis By Region, 2024
2.5 Industry Growth Scenarios – Conservative, Likely & Optimistic
2.6 Industry CxO’s Perspective
3. Market Overview
3.1 Market Dynamics
3.1.1 Drivers
3.1.2 Restraints
3.1.3 Opportunities
3.1.4 Key Market Trends
3.2 Industry PESTLE Analysis
3.3 Key Industry Forces (Porter’s) Impacting Market Growth
3.4 Industry Supply Chain Analysis
3.4.1 Raw Material Suppliers
3.4.2 Manufacturers
3.4.3 Distributors/Suppliers
3.4.4 Customers/End-Users
3.5 Industry Life Cycle Assessment
3.6 Parent Market Overview
3.7 Market Risk Assessment
4. Statistical Insights & Trends Reporting
4.1 Reimbursement & Coverage Trends
4.1.1 Country-wise Payer Coverage Analysis
4.1.2 Cost-Effectiveness and HTA Trends
4.2 R&D Investment and Funding Trends
4.2.1 Venture Capital and IPO Activity (2020–2024)
4.2.2 Public-Private and Regulatory-Backed Initiatives
4.3 Technology Integration Trends
4.3.1 AI and Predictive Analytics
4.3.2 Robotics, Navigation & Imaging Enhancements
4.4 Clinical Trials and Pipeline Progression Metrics
4.4.1 Intracranial Aneurysm Trials by Device Type
4.4.2 Enrollment and Procedural Outcome Benchmarks
4.5 Hospital and Center-Level Adoption Trends
4.5.1 Penetration of Endovascular Techniques in Tertiary Care Centers
4.5.2 Access to Advanced Neurovascular Devices by Facility Type
5. Intracranial Aneurysm Market Segmental Analysis & Forecast, By Product Type, 2021 – 2032, Value (USD Billion)
5.1 Introduction
5.2 Aneurysm Therapeutic Devices
5.2.1 Key Trends
5.2.2 Market Size & Forecast, 2021 – 2032
5.2.3 Clips
5.2.3.1 Key Trends
5.2.3.2 Market Size & Forecast, 2021 – 2032
5.2.4 Coils
5.2.4.1 Key Trends
5.2.4.2 Market Size & Forecast, 2021 – 2032
5.2.5 Intravascular Devices
5.2.5.1 Key Trends
5.2.5.2 Market Size & Forecast, 2021 – 2032
5.2.6 Flow Diverters
5.2.6.1 Key Trends
5.2.6.2 Market Size & Forecast, 2021 – 2032
5.2.7 Embolization Devices
5.2.7.1 Key Trends
5.2.7.2 Market Size & Forecast, 2021 – 2032
5.2.8 Occlusion Catheters
5.2.8.1 Key Trends
5.2.8.2 Market Size & Forecast, 2021 – 2032
5.2.9 Embolic Agents
5.2.9.1 Key Trends
5.2.9.2 Market Size & Forecast, 2021 – 2032
5.3 Aspiration Devices
5.3.1 Key Trends
5.3.2 Market Size & Forecast, 2021 – 2032
5.3.3 Aspiration Catheters
5.3.3.1 Key Trends
5.3.3.2 Market Size & Forecast, 2021 – 2032
5.3.4 Clot Retrieval Devices
5.3.4.1 Key Trends
5.3.4.2 Market Size & Forecast, 2021 – 2032
5.4 Access Devices
5.4.1 Key Trends
5.4.2 Market Size & Forecast, 2021 – 2032
5.4.3 Micro Catheters
5.4.3.1 Key Trends
5.4.3.2 Market Size & Forecast, 2021 – 2032
5.4.3 Guidewires
5.4.3.1 Key Trends
5.4.3.2 Market Size & Forecast, 2021 – 2032
6. Intracranial Aneurysm Market Segmental Analysis & Forecast, By Aneurysm Type, 2021 – 2032, Value (USD Billion)
6.1 Introduction
6.2 Saccular Aneurysm
6.2.1 Key Trends
6.2.2 Market Size & Forecast, 2021 – 2032
6.3 Fusiform Aneurysm
6.3.1 Key Trends
6.3.2 Market Size & Forecast, 2021 – 2032
6.4 Mycotic Aneurysm
6.4.1 Key Trends
6.4.2 Market Size & Forecast, 2021 – 2032
7. Intracranial Aneurysm Market Segmental Analysis & Forecast, By Treatment Type, 2021 – 2032, Value (USD Billion)
7.1 Introduction
7.2 Surgical Clipping
7.2.1 Key Trends
7.2.2 Market Size & Forecast, 2021 – 2032
7.3 Flow Diverters
7.3.1 Key Trends
7.3.2 Market Size & Forecast, 2021 – 2032
7.4 Others (Bypass surgery, Stent-assisted coiling)
7.4.1 Key Trends
7.4.2 Market Size & Forecast, 2021 – 2032
8. Intracranial Aneurysm Market Segmental Analysis & Forecast, By End-user, 2021 – 2032, Value (USD Billion)
8.1 Introduction
8.2 Hospitals
8.2.1 Key Trends
8.2.2 Market Size & Forecast, 2021 – 2032
8.3 Specialty Clinics
8.3.1 Key Trends
8.3.2 Market Size & Forecast, 2021 – 2032
8.4 Others (Ambulatory Surgical Centers, Academic Institutes)
8.4.1 Key Trends
8.4.2 Market Size & Forecast, 2021 – 2032
9. Intracranial Aneurysm Market Segmental Analysis & Forecast By Region, 2021 – 2025, Value (USD Billion)
9.1 Introduction
9.2 North America
9.2.1 Key Trends
9.2.2 Intracranial Aneurysm Market Size & Forecast, By Product Type, 2021 – 2032
9.2.3 Intracranial Aneurysm Market Size & Forecast, By Aneurysm Type, 2021 – 2032
9.2.4 Intracranial Aneurysm Market Size & Forecast, By Treatment Type, 2021 – 2032
9.2.5 Intracranial Aneurysm Market Size & Forecast, By End-user, 2021 – 2032
9.2.6 Intracranial Aneurysm Market Size & Forecast, By Country, 2021 – 2032
9.2.6.1 USA
9.2.6.1.1 Intracranial Aneurysm Market Size & Forecast, By Product Type, 2021 – 2032
9.2.6.1.2 Intracranial Aneurysm Market Size & Forecast, By Aneurysm Type, 2021 – 2032
9.2.6.1.3 Intracranial Aneurysm Market Size & Forecast, By Treatment Type, 2021 – 2032
9.2.6.1.4 Intracranial Aneurysm Market Size & Forecast, By End-user, 2021 – 2032
9.2.6.2 Canada
9.2.6.2.1 Intracranial Aneurysm Market Size & Forecast, By Product Type, 2021 – 2032
9.2.6.2.2 Intracranial Aneurysm Market Size & Forecast, By Aneurysm Type, 2021 – 2032
9.2.6.2.3 Intracranial Aneurysm Market Size & Forecast, By Treatment Type, 2021 – 2032
9.2.6.2.4 Intracranial Aneurysm Market Size & Forecast, By End-user, 2021 – 2032
9.3 Europe
9.3.1 Key Trends
9.3.2 Intracranial Aneurysm Market Size & Forecast, By Product Type, 2021 – 2032
9.3.3 Intracranial Aneurysm Market Size & Forecast, By Aneurysm Type, 2021 – 2032
9.3.4 Intracranial Aneurysm Market Size & Forecast, By Treatment Type, 2021 – 2032
9.3.5 Intracranial Aneurysm Market Size & Forecast, By End-user, 2021 – 2032
9.3.6 Intracranial Aneurysm Market Size & Forecast, By Country, 2021 – 2032
9.3.6.1 Germany
9.3.6.1.1 Intracranial Aneurysm Market Size & Forecast, By Product Type, 2021 – 2032
9.3.6.1.2 Intracranial Aneurysm Market Size & Forecast, By Aneurysm Type, 2021 – 2032
9.3.6.1.3 Intracranial Aneurysm Market Size & Forecast, By Treatment Type, 2021 – 2032
9.3.6.1.4 Intracranial Aneurysm Market Size & Forecast, By End-user, 2021 – 2032
9.3.6.2 UK
9.3.6.2.1 Intracranial Aneurysm Market Size & Forecast, By Product Type, 2021 – 2032
9.3.6.2.2 Intracranial Aneurysm Market Size & Forecast, By Aneurysm Type, 2021 – 2032
9.3.6.2.3 Intracranial Aneurysm Market Size & Forecast, By Treatment Type, 2021 – 2032
9.3.6.2.4 Intracranial Aneurysm Market Size & Forecast, By End-user, 2021 – 2032
9.3.6.3 France
9.3.6.3.1 Intracranial Aneurysm Market Size & Forecast, By Product Type, 2021 – 2032
9.3.6.3.2 Intracranial Aneurysm Market Size & Forecast, By Aneurysm Type, 2021 – 2032
9.3.6.3.3 Intracranial Aneurysm Market Size & Forecast, By Treatment Type, 2021 – 2032
9.3.6.3.4 Intracranial Aneurysm Market Size & Forecast, By End-user, 2021 – 2032
9.3.6.4 Italy
9.3.6.4.1 Intracranial Aneurysm Market Size & Forecast, By Product Type, 2021 – 2032
9.3.6.4.2 Intracranial Aneurysm Market Size & Forecast, By Aneurysm Type, 2021 – 2032
9.3.6.4.3 Intracranial Aneurysm Market Size & Forecast, By Treatment Type, 2021 – 2032
9.3.6.4.4 Intracranial Aneurysm Market Size & Forecast, By End-user, 2021 – 2032
9.3.6.5 Spain
9.3.6.5.1 Intracranial Aneurysm Market Size & Forecast, By Product Type, 2021 – 2032
9.3.6.5.2 Intracranial Aneurysm Market Size & Forecast, By Aneurysm Type, 2021 – 2032
9.3.6.5.3 Intracranial Aneurysm Market Size & Forecast, By Treatment Type, 2021 – 2032
9.3.6.5.4 Intracranial Aneurysm Market Size & Forecast, By End-user, 2021 – 2032
9.3.6.6 Russia
9.3.6.6.1 Intracranial Aneurysm Market Size & Forecast, By Product Type, 2021 – 2032
9.3.6.6.2 Intracranial Aneurysm Market Size & Forecast, By Aneurysm Type, 2021 – 2032
9.3.6.6.3 Intracranial Aneurysm Market Size & Forecast, By Treatment Type, 2021 – 2032
9.3.6.6.4 Intracranial Aneurysm Market Size & Forecast, By End-user, 2021 – 2032
9.3.6.7 Poland
9.3.6.7.1 Intracranial Aneurysm Market Size & Forecast, By Product Type, 2021 – 2032
9.3.6.7.2 Intracranial Aneurysm Market Size & Forecast, By Aneurysm Type, 2021 – 2032
9.3.6.7.3 Intracranial Aneurysm Market Size & Forecast, By Treatment Type, 2021 – 2032
9.3.6.7.4 Intracranial Aneurysm Market Size & Forecast, By End-user, 2021 – 2032
9.3.6.8 Rest of Europe
9.3.6.8.1 Intracranial Aneurysm Market Size & Forecast, By Product Type, 2021 – 2032
9.3.6.8.2 Intracranial Aneurysm Market Size & Forecast, By Aneurysm Type, 2021 – 2032
9.3.6.8.3 Intracranial Aneurysm Market Size & Forecast, By Treatment Type, 2021 – 2032
9.3.6.8.4 Intracranial Aneurysm Market Size & Forecast, By End-user, 2021 – 2032
9.4 Asia-Pacific
9.4.1 Key Trends
9.4.2 Intracranial Aneurysm Market Size & Forecast, By Product Type, 2021 – 2032
9.4.3 Intracranial Aneurysm Market Size & Forecast, By Aneurysm Type, 2021 – 2032
9.4.4 Intracranial Aneurysm Market Size & Forecast, By Treatment Type, 2021 – 2032
9.4.5 Intracranial Aneurysm Market Size & Forecast, By End-user, 2021 – 2032
9.4.6 Intracranial Aneurysm Market Size & Forecast, By Country, 2021 – 2032
9.4.6.1 China
9.4.6.1.1 Intracranial Aneurysm Market Size & Forecast, By Product Type, 2021 – 2032
9.4.6.1.2 Intracranial Aneurysm Market Size & Forecast, By Aneurysm Type, 2021 – 2032
9.4.6.1.3 Intracranial Aneurysm Market Size & Forecast, By Treatment Type, 2021 – 2032
9.4.6.1.4 Intracranial Aneurysm Market Size & Forecast, By End-user, 2021 – 2032
9.4.6.2 India
9.4.6.2.1 Intracranial Aneurysm Market Size & Forecast, By Product Type, 2021 – 2032
9.4.6.2.2 Intracranial Aneurysm Market Size & Forecast, By Aneurysm Type, 2021 – 2032
9.4.6.2.3 Intracranial Aneurysm Market Size & Forecast, By Treatment Type, 2021 – 2032
9.4.6.2.4 Intracranial Aneurysm Market Size & Forecast, By End-user, 2021 – 2032
9.4.6.3 Japan
9.4.6.3.1 Intracranial Aneurysm Market Size & Forecast, By Product Type, 2021 – 2032
9.4.6.3.2 Intracranial Aneurysm Market Size & Forecast, By Aneurysm Type, 2021 – 2032
9.4.6.3.3 Intracranial Aneurysm Market Size & Forecast, By Treatment Type, 2021 – 2032
9.4.6.3.4 Intracranial Aneurysm Market Size & Forecast, By End-user, 2021 – 2032
9.4.6.4 South Korea
9.4.6.4.1 Intracranial Aneurysm Market Size & Forecast, By Product Type, 2021 – 2032
9.4.6.4.2 Intracranial Aneurysm Market Size & Forecast, By Aneurysm Type, 2021 – 2032
9.4.6.4.3 Intracranial Aneurysm Market Size & Forecast, By Treatment Type, 2021 – 2032
9.4.6.4.4 Intracranial Aneurysm Market Size & Forecast, By End-user, 2021 – 2032
9.4.6.5 Australia
9.4.6.5.1 Intracranial Aneurysm Market Size & Forecast, By Product Type, 2021 – 2032
9.4.6.5.2 Intracranial Aneurysm Market Size & Forecast, By Aneurysm Type, 2021 – 2032
9.4.6.5.3 Intracranial Aneurysm Market Size & Forecast, By Treatment Type, 2021 – 2032
9.4.6.5.4 Intracranial Aneurysm Market Size & Forecast, By End-user, 2021 – 2032
9.4.6.6 ASEAN Countries
9.4.6.6.1 Intracranial Aneurysm Market Size & Forecast, By Product Type, 2021 – 2032
9.4.6.6.2 Intracranial Aneurysm Market Size & Forecast, By Aneurysm Type, 2021 – 2032
9.4.6.6.3 Intracranial Aneurysm Market Size & Forecast, By Treatment Type, 2021 – 2032
9.4.6.6.4 Intracranial Aneurysm Market Size & Forecast, By End-user, 2021 – 2032
9.4.6.7 Rest of Asia-Pacific
9.4.6.7.1 Intracranial Aneurysm Market Size & Forecast, By Product Type, 2021 – 2032
9.4.6.7.2 Intracranial Aneurysm Market Size & Forecast, By Aneurysm Type, 2021 – 2032
9.4.6.7.3 Intracranial Aneurysm Market Size & Forecast, By Treatment Type, 2021 – 2032
9.4.6.7.4 Intracranial Aneurysm Market Size & Forecast, By End-user, 2021 – 2032
9.5 Latin America
9.5.1 Key Trends
9.5.2 Intracranial Aneurysm Market Size & Forecast, By Product Type, 2021 – 2032
9.5.3 Intracranial Aneurysm Market Size & Forecast, By Aneurysm Type, 2021 – 2032
9.5.4 Intracranial Aneurysm Market Size & Forecast, By Treatment Type, 2021 – 2032
9.5.5 Intracranial Aneurysm Market Size & Forecast, By End-user, 2021 – 2032
9.5.6 Intracranial Aneurysm Market Size & Forecast, By Country, 2021 – 2032
9.5.6.1 Brazil
9.5.6.1.1 Intracranial Aneurysm Market Size & Forecast, By Product Type, 2021 – 2032
9.5.6.1.2 Intracranial Aneurysm Market Size & Forecast, By Aneurysm Type, 2021 – 2032
9.5.6.1.3 Intracranial Aneurysm Market Size & Forecast, By Treatment Type, 2021 – 2032
9.5.6.1.4 Intracranial Aneurysm Market Size & Forecast, By End-user, 2021 – 2032
9.5.6.2 Argentina
9.5.6.2.1 Intracranial Aneurysm Market Size & Forecast, By Product Type, 2021 – 2032
9.5.6.2.2 Intracranial Aneurysm Market Size & Forecast, By Aneurysm Type, 2021 – 2032
9.5.6.2.3 Intracranial Aneurysm Market Size & Forecast, By Treatment Type, 2021 – 2032
9.5.6.2.4 Intracranial Aneurysm Market Size & Forecast, By End-user, 2021 – 2032
9.5.6.3 Mexico
9.5.6.3.1 Intracranial Aneurysm Market Size & Forecast, By Product Type, 2021 – 2032
9.5.6.3.2 Intracranial Aneurysm Market Size & Forecast, By Aneurysm Type, 2021 – 2032
9.5.6.3.3 Intracranial Aneurysm Market Size & Forecast, By Treatment Type, 2021 – 2032
9.5.6.3.4 Intracranial Aneurysm Market Size & Forecast, By End-user, 2021 – 2032
9.5.6.4 Colombia
9.5.6.4.1 Intracranial Aneurysm Market Size & Forecast, By Product Type, 2021 – 2032
9.5.6.4.2 Intracranial Aneurysm Market Size & Forecast, By Aneurysm Type, 2021 – 2032
9.5.6.4.3 Intracranial Aneurysm Market Size & Forecast, By Treatment Type, 2021 – 2032
9.5.6.4.4 Intracranial Aneurysm Market Size & Forecast, By End-user, 2021 – 2032
9.5.6.5 Rest of Latin America
9.5.6.5.1 Intracranial Aneurysm Market Size & Forecast, By Product Type, 2021 – 2032
9.5.6.5.2 Intracranial Aneurysm Market Size & Forecast, By Aneurysm Type, 2021 – 2032
9.5.6.5.3 Intracranial Aneurysm Market Size & Forecast, By Treatment Type, 2021 – 2032
9.5.6.5.4 Intracranial Aneurysm Market Size & Forecast, By End-user, 2021 – 2032
9.6 Middle East & Africa
9.6.1 Key Trends
9.6.2 Intracranial Aneurysm Market Size & Forecast, By Product Type, 2021 – 2032
9.6.3 Intracranial Aneurysm Market Size & Forecast, By Aneurysm Type, 2021 – 2032
9.6.4 Intracranial Aneurysm Market Size & Forecast, By Treatment Type, 2021 – 2032
9.6.5 Intracranial Aneurysm Market Size & Forecast, By End-user, 2021 – 2032
9.6.6 Intracranial Aneurysm Market Size & Forecast, By Country, 2021 – 2032
9.6.6.1 UAE
9.6.6.1.1 Intracranial Aneurysm Market Size & Forecast, By Product Type, 2021 – 2032
9.6.6.1.2 Intracranial Aneurysm Market Size & Forecast, By Aneurysm Type, 2021 – 2032
9.6.6.1.3 Intracranial Aneurysm Market Size & Forecast, By Treatment Type, 2021 – 2032
9.6.6.1.4 Intracranial Aneurysm Market Size & Forecast, By End-user, 2021 – 2032
9.6.6.2 Saudi Arabia
9.6.6.2.1 Intracranial Aneurysm Market Size & Forecast, By Product Type, 2021 – 2032
9.6.6.2.2 Intracranial Aneurysm Market Size & Forecast, By Aneurysm Type, 2021 – 2032
9.6.6.2.3 Intracranial Aneurysm Market Size & Forecast, By Treatment Type, 2021 – 2032
9.6.6.2.4 Intracranial Aneurysm Market Size & Forecast, By End-user, 2021 – 2032
9.6.6.3 Qatar
9.6.6.3.1 Intracranial Aneurysm Market Size & Forecast, By Product Type, 2021 – 2032
9.6.6.3.2 Intracranial Aneurysm Market Size & Forecast, By Aneurysm Type, 2021 – 2032
9.6.6.3.3 Intracranial Aneurysm Market Size & Forecast, By Treatment Type, 2021 – 2032
9.6.6.3.4 Intracranial Aneurysm Market Size & Forecast, By End-user, 2021 – 2032
9.6.6.4 Egypt
9.6.6.4.1 Intracranial Aneurysm Market Size & Forecast, By Product Type, 2021 – 2032
9.6.6.4.2 Intracranial Aneurysm Market Size & Forecast, By Aneurysm Type, 2021 – 2032
9.6.6.4.3 Intracranial Aneurysm Market Size & Forecast, By Treatment Type, 2021 – 2032
9.6.6.4.4 Intracranial Aneurysm Market Size & Forecast, By End-user, 2021 – 2032
9.6.6.5 South Africa
9.6.6.5.1 Intracranial Aneurysm Market Size & Forecast, By Product Type, 2021 – 2032
9.6.6.5.2 Intracranial Aneurysm Market Size & Forecast, By Aneurysm Type, 2021 – 2032
9.6.6.5.3 Intracranial Aneurysm Market Size & Forecast, By Treatment Type, 2021 – 2032
9.6.6.5.4 Intracranial Aneurysm Market Size & Forecast, By End-user, 2021 – 2032
9.6.6.6 Rest of Middle East & Africa
9.6.6.6.1 Intracranial Aneurysm Market Size & Forecast, By Product Type, 2021 – 2032
9.6.6.6.2 Intracranial Aneurysm Market Size & Forecast, By Aneurysm Type, 2021 – 2032
9.6.6.6.3 Intracranial Aneurysm Market Size & Forecast, By Treatment Type, 2021 – 2032
9.6.6.6.4 Intracranial Aneurysm Market Size & Forecast, By End-user, 2021 – 2032
10. Competitive Landscape
10.1 Key Players' Positioning
10.2 Competitive Developments
10.2.1 Key Strategies Adopted (%), By Key Players, 2024
10.2.2 Year-Wise Strategies & Development, 2021 – 2025
10.2.3 Number of Strategies Adopted by Key Players, 2024
10.3 Market Share Analysis, 2024
10.4 Product/Service & Application Benchmarking
10.4.1 Product/Service Specifications & Features By Key Players
10.4.2 Product/Service Heatmap By Key Players
10.4.3 Application Heatmap By Key Players
10.5 Industry Start-Up & Innovation Landscape
10.6 Key Company Profiles
10.6 Key Company Profiles
10.6.1 Medtronic
10.6.1.1 Company Overview & Snapshot
10.6.1.2 Product/Service Portfolio
10.6.1.3 Key Company Financials
10.6.1.4 SWOT Analysis
10.6.2 Stryker
10.6.2.1 Company Overview & Snapshot
10.6.2.2 Product/Service Portfolio
10.6.2.3 Key Company Financials
10.6.2.4 SWOT Analysis
10.6.3 MicroPort Scientific Corporation
10.6.3.1 Company Overview & Snapshot
10.6.3.2 Product/Service Portfolio
10.6.3.3 Key Company Financials
10.6.3.4 SWOT Analysis
10.6.4 Johnson & Johnson Services, Inc.
10.6.4.1 Company Overview & Snapshot
10.6.4.2 Product/Service Portfolio
10.6.4.3 Key Company Financials
10.6.4.4 SWOT Analysis
10.6.5 MicroVention Inc.
10.6.5.1 Company Overview & Snapshot
10.6.5.2 Product/Service Portfolio
10.6.5.3 Key Company Financials
10.6.5.4 SWOT Analysis
10.6.6 B. Braun SE
10.6.6.1 Company Overview & Snapshot
10.6.6.2 Product/Service Portfolio
10.6.6.3 Key Company Financials
10.6.6.4 SWOT Analysis
10.6.7 Integra LifeSciences
10.6.7.1 Company Overview & Snapshot
10.6.7.2 Product/Service Portfolio
10.6.7.3 Key Company Financials
10.6.7.4 SWOT Analysis
10.6.8 RAUMEDIC AG
10.6.8.1 Company Overview & Snapshot
10.6.8.2 Product/Service Portfolio
10.6.8.3 Key Company Financials
10.6.8.4 SWOT Analysis
10.6.9 Terumo Corporation
10.6.9.1 Company Overview & Snapshot
10.6.9.2 Product/Service Portfolio
10.6.9.3 Key Company Financials
10.6.9.4 SWOT Analysis
10.6.10 Delta Surgical
10.6.10.1 Company Overview & Snapshot
10.6.10.2 Product/Service Portfolio
10.6.10.3 Key Company Financials
10.6.10.4 SWOT Analysis
10.6.11 Penumbra, Inc.
10.6.11.1 Company Overview & Snapshot
10.6.11.2 Product/Service Portfolio
10.6.11.3 Key Company Financials
10.6.11.4 SWOT Analysis
10.6.12 Balt
10.6.12.1 Company Overview & Snapshot
10.6.12.2 Product/Service Portfolio
10.6.12.3 Key Company Financials
10.6.12.4 SWOT Analysis
10.6.13 Wallaby Medical
10.6.13.1 Company Overview & Snapshot
10.6.13.2 Product/Service Portfolio
10.6.13.3 Key Company Financials
10.6.13.4 SWOT Analysis
10.6.14 Shape Memory Medical Inc.
10.6.14.1 Company Overview & Snapshot
10.6.14.2 Product/Service Portfolio
10.6.14.3 Key Company Financials
10.6.14.4 SWOT Analysis
10.6.15 Zylox-Tonbridge Medical Technology Co., Ltd.
10.6.15.1 Company Overview & Snapshot
10.6.15.2 Product/Service Portfolio
10.6.15.3 Key Company Financials
10.6.15.4 SWOT Analysis
10.6.16 Spartan Micro, Inc.
10.6.16.1 Company Overview & Snapshot
10.6.16.2 Product/Service Portfolio
10.6.16.3 Key Company Financials
10.6.16.4 SWOT Analysis
10.6.17 Mizuho Medical Co., Ltd.
10.6.17.1 Company Overview & Snapshot
10.6.17.2 Product/Service Portfolio
10.6.17.3 Key Company Financials
10.6.17.4 SWOT Analysis
10.6.18 Lepu Medical Technology Co., Ltd.
10.6.18.1 Company Overview & Snapshot
10.6.18.2 Product/Service Portfolio
10.6.18.3 Key Company Financials
10.6.18.4 SWOT Analysis
10.6.19 Phenox GmbH
10.6.19.1 Company Overview & Snapshot
10.6.19.2 Product/Service Portfolio
10.6.19.3 Key Company Financials
10.6.19.4 SWOT Analysis
10.6.20 Peter LAZIC GmbH
10.6.20.1 Company Overview & Snapshot
10.6.20.2 Product/Service Portfolio
10.6.20.3 Key Company Financials
10.6.20.4 SWOT Analysis
11. Analyst Recommendations
11.1 SNS Insider Opportunity Map
11.2 Industry Low-Hanging Fruit Assessment
11.3 Market Entry & Growth Strategy
11.4 Analyst Viewpoint & Suggestions On Market Growth
12. Assumptions
13. Disclaimer
14. Appendix
14.1 List Of Tables
14.2 List Of Figures
An accurate research report requires proper strategizing as well as implementation. There are multiple factors involved in the completion of good and accurate research report and selecting the best methodology to compete the research is the toughest part. Since the research reports we provide play a crucial role in any company’s decision-making process, therefore we at SNS Insider always believe that we should choose the best method which gives us results closer to reality. This allows us to reach at a stage wherein we can provide our clients best and accurate investment to output ratio.
Each report that we prepare takes a timeframe of 350-400 business hours for production. Starting from the selection of titles through a couple of in-depth brain storming session to the final QC process before uploading our titles on our website we dedicate around 350 working hours. The titles are selected based on their current market cap and the foreseen CAGR and growth.
The 5 steps process:
Step 1: Secondary Research:
Secondary Research or Desk Research is as the name suggests is a research process wherein, we collect data through the readily available information. In this process we use various paid and unpaid databases which our team has access to and gather data through the same. This includes examining of listed companies’ annual reports, Journals, SEC filling etc. Apart from this our team has access to various associations across the globe across different industries. Lastly, we have exchange relationships with various university as well as individual libraries.
Step 2: Primary Research
When we talk about primary research, it is a type of study in which the researchers collect relevant data samples directly, rather than relying on previously collected data. This type of research is focused on gaining content specific facts that can be sued to solve specific problems. Since the collected data is fresh and first hand therefore it makes the study more accurate and genuine.
We at SNS Insider have divided Primary Research into 2 parts.
Part 1 wherein we interview the KOLs of major players as well as the upcoming ones across various geographic regions. This allows us to have their view over the market scenario and acts as an important tool to come closer to the accurate market numbers. As many as 45 paid and unpaid primary interviews are taken from both the demand and supply side of the industry to make sure we land at an accurate judgement and analysis of the market.
This step involves the triangulation of data wherein our team analyses the interview transcripts, online survey responses and observation of on filed participants. The below mentioned chart should give a better understanding of the part 1 of the primary interview.
Part 2: In this part of primary research the data collected via secondary research and the part 1 of the primary research is validated with the interviews from individual consultants and subject matter experts.
Consultants are those set of people who have at least 12 years of experience and expertise within the industry whereas Subject Matter Experts are those with at least 15 years of experience behind their back within the same space. The data with the help of two main processes i.e., FGDs (Focused Group Discussions) and IDs (Individual Discussions). This gives us a 3rd party nonbiased primary view of the market scenario making it a more dependable one while collation of the data pointers.
Step 3: Data Bank Validation
Once all the information is collected via primary and secondary sources, we run that information for data validation. At our intelligence centre our research heads track a lot of information related to the market which includes the quarterly reports, the daily stock prices, and other relevant information. Our data bank server gets updated every fortnight and that is how the information which we collected using our primary and secondary information is revalidated in real time.
Step 4: QA/QC Process
After all the data collection and validation our team does a final level of quality check and quality assurance to get rid of any unwanted or undesired mistakes. This might include but not limited to getting rid of the any typos, duplication of numbers or missing of any important information. The people involved in this process include technical content writers, research heads and graphics people. Once this process is completed the title gets uploader on our platform for our clients to read it.
Step 5: Final QC/QA Process:
This is the last process and comes when the client has ordered the study. In this process a final QA/QC is done before the study is emailed to the client. Since we believe in giving our clients a good experience of our research studies, therefore, to make sure that we do not lack at our end in any way humanly possible we do a final round of quality check and then dispatch the study to the client.
Key Segments
By Product Type
Aneurysm Therapeutic Devices
Clips
Coils
Intravascular Devices
Flow Diverters
Embolization Devices
Occlusion Catheters
Embolic Agents
Aspiration Devices
Aspiration Catheters
Clot Retrieval Devices
Access Devices
Micro Catheters
Guidewires
By Aneurysm Type
Saccular Aneurysm
Fusiform Aneurysm
Mycotic Aneurysm
By Treatment Type
Surgical Clipping
Endovascular Coiling
Flow Diverters
Others (Bypass surgery, Stent-assisted coiling)
By End-User
Hospitals
Specialty Clinics
Others (Ambulatory Surgical Centers, Academic Institutes)
Request for Segment Customization as per your Business Requirement: Segment Customization Request
Regional Coverage:
North America
US
Canada
Europe
Germany
France
UK
Italy
Spain
Russia
Poland
Rest of Europe
Asia Pacific
China
India
Japan
South Korea
Australia
ASEAN Countries
Rest of Asia Pacific
Middle East & Africa
UAE
Saudi Arabia
Qatar
Egypt
South Africa
Rest of Middle East & Africa
Latin America
Brazil
Argentina
Mexico
Colombia
Rest of Latin America
Request for Country Level Research Report: Country Level Customization Request
Available Customization
With the given market data, SNS Insider offers customization as per the company’s specific needs. The following customization options are available for the report:
Detailed Volume Analysis
Criss-Cross segment analysis (e.g., Product X Application)
Competitive Product Benchmarking
Geographic Analysis
Additional countries in any of the regions
Customized Data Representation
Detailed analysis and profiling of additional market players